Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-07-26
1998-05-26
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 53, 514 78, A61K 3170, A61K 31715, A61K 31685
Patent
active
057564698
ABSTRACT:
The present invention is based, in part, upon the discovery that the use of pyruvate in combination with a cortisol blocker, such as phosphatidylserine, produces a synergistic effect in increasing lean body mass or muscle tissue, decreasing fat deposition, increasing endurance and athletic performance of a mammal consuming same. The invention also relates to a method of treating the catabolic effects of diseases such as cancer and AIDS by the administration of pyruvate and a cortisol blocker.
The present invention also discloses a synergistic composition comprising pyruvate and a cortisol blocker. More specifically, the present invention relates to a composition which comprises pyruvate and/or derivatives of pyruvate and phosphatidylserine.
REFERENCES:
patent: 4351835 (1982-09-01), Stanko
patent: 4415576 (1983-11-01), Stanko
patent: 4548937 (1985-10-01), Stanko
patent: 4645764 (1987-02-01), Stanko
patent: 4812479 (1989-03-01), Stanko
patent: 4874790 (1989-10-01), Stanko
patent: 4981687 (1991-01-01), Fregly et al.
patent: 5028440 (1991-07-01), Nissen
patent: 5087472 (1992-02-01), Nissen
patent: 5089477 (1992-02-01), Fregly et al.
patent: 5134162 (1992-07-01), Stanko
patent: 5147650 (1992-09-01), Fregly et al.
patent: 5236712 (1993-08-01), Fregly et al.
patent: 5238684 (1993-08-01), Fregly et al.
patent: 5256697 (1993-10-01), Miller et al.
patent: 5283260 (1994-02-01), Miller et al.
patent: 5294606 (1994-03-01), Hastings
patent: 5294641 (1994-03-01), Stanko
patent: 5312985 (1994-05-01), Dhaon et al.
patent: 5348979 (1994-09-01), Nissen et al.
patent: 5360613 (1994-11-01), Nissen
patent: 5428072 (1995-06-01), Cook et al.
patent: 5430066 (1995-07-01), Cook et al.
patent: 5472980 (1995-12-01), Miller
patent: 5480909 (1996-02-01), Stanko
patent: 5508308 (1996-04-01), Miller et al.
patent: 5536751 (1996-07-01), Bunger
"Conjugated Linoleic Acid (CLA)", 1996 Supplement Review, 19-22, 1966.
Monteleone, et al., "Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men", European Journal at Clinical Pharmacology, 1992.
Monteleone, et al., "Effects of Phosphatidylserine on the Neuroendocrine Response to Physical Stress in Humans", Neuroendocrinology, 1990; 52:243-248.
Nestler, et al."Dehydroepiandrosterone Reduces Serum Low Density Lipoprotein Levels and Body Fat but Does not Alter Insulin Sensitivity in Normal Men", Journal of Clinical Endocrinology and Metabolism, vol. 66, No. 1:57-61, 1988.
Morales, et al., "Effects of Replacement Dose of Dehydroepianodrosterone in Men and Women of Advancing Age", Journal of Clinical Endocrinology and Metabolism, vol. 78, No. 6:1360-1367, 1994.
Kurzman, et al., "Reduction in Body Weight and Cholesterol in Spontaneously Obese Dogs By Dehydroepiandrosterone", International Journal of Obesity, 14:95-104, 1990.
Heymsfield, et al., "Chemical and elemental analysis of humans in vivo using improved body composition models", American Journal of Physiology, 261:E190-E198,1991.
Brunner, "HMB, KIC and Leucine--Anticatabolic Bodybuilding Nutrients From the Same Branched Chain", IM, 100-101, Jul. 1996.
Fritz, "Phosphatidylserine--Have We Found a Medically Proven Cortisol Antagonist at Last?", IM, 74-75, Feb. 1996.
Brunner, "Phosphatidylserine", IM, 68-70, Aug. 1996.
Block, "Amino Acid Handbook--Methods and Results of Protein Analysis".
"MLO--Gain Muscle & Lose Bodyfat--Hardbody--Muscle-Zyme / Questions & Answers", Pamphlet.
"MLO--Hardbody--Muscle-Zyme", Sample Product Label.
"First Strike--World's First Cortisol Blocker", Sales Aide.
"Atletika--Thriad Centered Training", Sales Brochure.
"Cortistat-PS", Advertisement.
"Develop Peak Performance Naturally--Corti-PS Sports Supplement", Sales Aide.
"Corti-PS-30P", Technical Data Sheet.
"Corti-PS-20P", Technical Data Sheet.
"Corti-PS-20F", Technical Data Sheet.
Memorandum regarding Corti-PS Phosphatidylserine (PS) dated Aug. 24, 1995.
Nickey Donald O.
Weddington Kevin E.
LandOfFree
Composition of pyruvate and anti-cortisol compounds and method f does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition of pyruvate and anti-cortisol compounds and method f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition of pyruvate and anti-cortisol compounds and method f will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960160